Update on endothelin receptor nomenclature.
Regul Pept 66:155–162ĭavenport AP (2002) International Union of Pharmacology. Nature 348:730–732īernmek H, Peng KC, Angelova K, Ergul A, Puett D (1996) Endothelin degradation by vascular smooth muscle cells. FEBS Lett 228:285–289Īrai H, Hori S, Aramori I, Ohkubo H, Nakanishi S (1990) Cloning and expression of a cDNA encoding an endothelin receptor. Ukena D, Dent G, Birke F, Robaut C, Sybrecht G, Barnes PJ (1988) Radioligand binding of antagonists of platelet activating factor to intact human platelets. Terashita ZI, Imura Y, Nishikawa K (1985) Inhibition by CV- 3988 of the binding of -platelet activating factor (PAF) to the platelet. Summers JB, Albert DH (1995) Platelet activating factor antagonists. Seo KH, Lee HS, Jung B, Ko HM, Cvhoi JH, Park SJ, Choi IH, Lee KH, Im SY (2004) Estrogen enhances angiogenesis through a pathway involving platelet-activating factor-mediated nuclear factor- κB activation. Ring PC, Seldon PM, Bernes PJ, Giembycz MA (1992) Pharmacological characterization of a receptor for platelet activating factor on guinea pig peritoneal macrophages using Apafant, a selective and competitive platelet activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation. Koltai M, Guinot P, Hosford D, Braquet PG (1994) Platelet-activating factor antagonists: scientific background and possible clinical applications. Izumi T, Shimizu T (1995) Platelet-activating factor: gene expression and signal transduction. Ishii S, Shimizu T (2000) Platelet-activating factor (PAF) receptor and genetically engineered PAF mutant mice. Hwang SB, Lee CSC, Cheah MJ, Shen TY (1983) Specific receptor sites for 1- O-alkyl-2- O-acetyl-sn-glycero-3-phosphocholine (platelet activating factor) on rabbit platelet and guinea pig smooth muscle membrane. Hikiji H, Ishii S, Shindou H, Takato T, Shimizu T (2004) Absence of platelet-activating factor receptor protects mice from osteoporosis following ovariectomy. Handley DA (1990) Preclinical and clinical pharmacology of platelet-activating factor receptor antagonists. FEBS Lett 244:365–368ĭent G, Ukena D, Sybrecht GW, Barnes PJ (1989b) WEB- 2086 labels platelet activating factor in guinea pig and human lung. Biochem J 292:617–629ĭent G, Ukena D, Chanez P, Sybrecht GW, Barnes J (1989a) Characterization of PAF receptors on human neutrophils using the specific antagonist WEB-2086: correlation between binding and function. J Pharmacol Exp Ther 241:974–981Ĭhao W, Olson MS (1993) Platelet-activating factor: receptors and signal transduction. Exp Eye Res 80:453–463Ĭasals-Stenzel J, Muacevic G, Weber KH (1987) Pharmacological actions of WEB-2086, a new specific antagonist of platelet activating factor. J Pharmacol Toxicol Methods 36:53–62īazan HE (2005) Cellular and molecular events in corneal wound healing: significance of lipid signalling. Balsa D, Merlos M, Giral M, Ferrando R, García-Rafanell J, Forn J (1996) Characterization of Apafant binding to PAF receptor on rabbit platelet membranes: a comparison of a microplate filtration system and a standard method.
0 kommentar(er)
